Listing in London – King & Spalding carries US biotech to AIM listing Legal Business11 May 2015Corporate and M&AUS King & Spalding’s recent recruits in the City have helped handle Californian biotech company Verseon £300m stock market listing in London while Covington & Burling advised from San Francisco.Your limit of 1 article in 30 days is up. Please login for full access or subscribe. Corporate users - click here for simple access (no password needed). For more information, please contact [email protected] Related ContentMore in this category‘There’s definitely competition around rates’ – Clifford Chance and Linklaters match Cravath bonuses for US associates‘This was not a good idea and we’re entitled to say so’ – LLP tax proposals get short shriftRevolving Doors: Proskauer boosts London finance team as Paul Weiss picks up another Kirkland partner‘For us, it all came together’ – how Proskauer built a London high yield offering in 12 monthsSlaughters, Gibson Dunn lead on Daily Mail’s £500m Telegraph Media Group acquisitionCohen & Gresser follows McDermott in eyeing up external investmentClifford Chance names Cohen first New York managing partner amid fresh bid to crack America with Houston office openingInternational Women’s Day 2022: Barbara L. Becker, chair & managing partner, Gibson Dunn, New YorkInternational Women’s Day 2022: Perlette Jura, Gibson Dunn, Los Angeles – disputes